BOT continue to progress hitting all targets and in a timely manner, reducing the risk as they progress through the regulatory minefield, surpassing Milestones , the next Big Target is near term revenue $
Ann: Australian Ethics approval for Acne Study, page-17
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $671.1M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.8¢ | $954.2K | 2.577M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 89025 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 1729 | 1 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |